Monday 9 February 2026
Home      All news      Contact us      RSS     
globalnews.ca - 5 days ago

Novo Nordisk says Canada will hit semaglutide sales as patents expire

Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.


Latest News
Hashtags:   

Nordisk

 | 

Canada

 | 

semaglutide

 | 

sales

 | 

patents

 | 

expire

 | 

Sources